Clear link between androgenetic alopecia and benign prostate hyperplasia

NewsGuard 100/100 Score

Spanish scientists have confirmed that there is a clear relationship between androgenetic alopecia (common premature baldness) and benign prostate hyperplasia (BPH), a benign enlargement of the prostate that appears in aging men and is associated with certain hormones as dihydrotestosterone. This condition appears in 50% of men over 60 year old and causes voiding syndrome i.e. urinary frequency.

In the light of the study published in the Journal of the American Academy of Dermatology, men with premature alopecia are at a higher risk for BPH than the rest of men. This article was awarded the 1st prize at the 68 Annual Conference of the American Academy of Dermatology celebrated in Miami.

Androgenetic alopecia is the most common form of baldness, and is more frequent in men tan in women. It has a hereditary component and gradually evolves when no treatment is provided. Benign prostate hyperplasia is also the most common prostate condition and causes an abnormal and irregular enlargement of the glands adjoining the urethra. This causes the growth of a benign tumor that blocks urine output.

A Study Including 87 Men

This study included a total of 87 men, of which 45 were diagnosed with androgenetic alopecia by a dermatologist, while the other 42 were healthy men who acted as controls. Measurements were taken of prostate volume by transrectal ultrasound and urinary flow by urinary flowmetry. Hormone levels and International Index of Erectile Function were also assessed.

The results of this study proved that there was a clear and direct association between premature alopecia and benign prostate hyperplasia.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
The effectiveness of statins in PCOS management